The UK’s Advanced Manufacturing Funding Gap: From Lab to Factory

UK advanced manufacturing is enjoying something of a renaissance — yet the companies driving it often struggle to raise the capital that would carry their technology from the laboratory to the factory floor. The sector recorded the largest rise in investment value of any Industrial Strategy priority area last year, but that capital is pooling in a handful of very large rounds, concentrated in one corner of the country, and has yet to reach much of the sector it is meant to serve. For investors and advisers, that mismatch is where the opportunity now lies, and April’s changes to the Enterprise Investment Scheme (EIS) have opened it up to private clients willing to back the right expertise. The question is no longer whether the sector is attractive, but where in it the capital is actually missing — and who is positioned to supply it.

Where the money is going

The British Business Bank’s latest equity tracker puts the rise in advanced manufacturing investment at 49%, the strongest of the eight Industrial Strategy priority sectors, while life sciences and financial services saw investment fall. The encouraging reading is that larger investors now treat industrial technology as a serious category, which improves the odds that an EIS-backed company can find follow-on capital when it needs to grow.

Look more closely, though, and a gap appears. Three megadeals accounted for around £3 billion of the £4.6 billion invested in UK equity over the past quarter, while investment into smaller businesses fell 43% in the same period. Headline growth therefore overstates how much capital actually reaches the size of company an EIS portfolio typically holds - and the shortfall is not uniform. On EverQuest’s own analysis of ONS, NISRA and PitchBook data, it falls along three distinct lines.

Three ways the capital misses the mark

The first gap is geographic. Advanced manufacturing is a UK-wide activity, but its venture capital is not. London, the East and the South East hold around a quarter of the country’s advanced manufacturing jobs yet attract roughly three-quarters of the sector’s venture capital; London alone, with about 2% of the jobs, takes some 45% of the money. A company proving a process in the North East or the Midlands is simply further from the nearest investor - there are around 45 venture capital offices per 100 fast-growing firms in London, against five across the rest of the UK.

The second gap opens as companies scale. Across 601 UK advanced manufacturing financing rounds between 2020 and 2025, UK investors led 60% of seed rounds but only 32% of Series B rounds - the stage at which a company builds its demonstration plant. By that point, six in ten rounds are led from overseas. Domestic capital, in other words, thins at precisely the moment the capital requirement and the technical risk are greatest. (The rounds here are grouped by size - seed under £5 million, Series A £5–10 million, Series B £10–30 million - rather than by independently verified stage definitions, and a UK investor stepping back is not on its own proof of unmet demand, since overseas capital fills part of it. The direction of travel, however, is consistent.)

The third gap is understanding. The Department for Business and Trade’s review of access to finance for advanced manufacturing scale-ups reports that 45% of manufacturing and engineering scale-ups feel investors often lack understanding of their sector, and 35% have been deterred by investors’ short-term focus — understandable when a scale-up may be seven or more years from an exit, well beyond a typical venture fund’s horizon. The ScaleUp Institute’s 2025 survey found that 53% of advanced manufacturing scale-ups had insufficient capital to support their ambitions. The shortfall is as much about the right kind of investor as the quantity of money.

Proving a process in the laboratory is cheap by comparison; a pilot or demonstration plant means paying for equipment and sites before revenue arrives. The UK Innovation Report 2026 found that domestic scale-up activity clusters in a few sectors, mostly outside manufacturing, and that too many UK companies are acquired abroad or choose to scale overseas. For investors with the right expertise, thinner competition at this stage is where the opportunity begins.

Why this stage suits EIS

Businesses at this stage also hold assets that software companies rarely have. Patented processes and physical plant can be valued and, if necessary, sold on their own merits - though investors’ capital remains fully at risk. Demand rests on firmer ground, too: supply-chain security and domestic industrial capability are now long-term policy aims, which gives these companies customers whose needs are unlikely to fade with the next shift in investor sentiment.

The EIS rules have now caught up. Since April, the annual and lifetime sums a company can raise under the scheme have doubled, and the gross assets test has risen to £30 million before a share issue and £35 million after. That asset-test increase is particularly consequential for early-stage manufacturers: building a plant adds to the balance sheet quickly, and under the old £15 million ceiling a company could lose eligibility just as its capital needs peaked. The higher limits also let EIS reach further up the funding ladder, into the scale-up rounds where domestic lead investors begin to step back.

That makes EIS one of the more direct routes into this stage for private clients. Public money is arriving, but the British Business Bank’s expanding direct-equity programme writes initial cheques that typically start at £10 million and targets later-stage companies. The scale-up rounds that carry a manufacturer from pilot line to demonstration plant often sit below that line - which is where EIS capital can do its most useful work, supporting technically validated businesses before they reach the larger commercialisation rounds where specialist capital becomes even harder to secure. With upfront VCT relief now cut to 20%, EIS also looks relatively more attractive for clients seeking this exposure.

Where expertise earns its place

The rounds UK investors step back from are precisely the ones that reward technical judgement. Commissioning an industrial process tests engineering judgement as much as commercial judgement; a manager who has scaled processes before can tell a normal delay from a flawed design. That knowledge shapes when to commit further capital and how to support management through the most demanding stretch of a company’s growth - and it is the specialist understanding the sector says it is missing.

It is also where EverQuest is built to operate. The firm works alongside the Centre for Process Innovation (CPI), the UK’s national centre for scaling up new manufacturing. Companies come to CPI to scale up, so EverQuest meets them early, and CPI’s engineers check that a process works at scale before further capital is committed - diligence few generalist investors can replicate.

DEScycle shows how this works in practice. EverQuest and CPI backed the deep-technology company after it achieved metal-recovery rates above 99% from electronic waste at bench scale, with much of that development carried out alongside CPI’s engineers. It is now commissioning a demonstration plant at the Wilton Centre, with a joint venture already formed to deliver its first commercial facility. Working that closely with a company lets an investor watch a process prove itself at industrial scale, and judge, from the inside, when it is ready for the next tranche of capital.

Britain’s manufacturing renaissance will be decided at the scale-up stage, where laboratory promise has to prove itself as industrial output. Capital has so far gathered further up the market, in one region and in a handful of outsized rounds, leaving that stage short of the right kind of funding at the very moment policy has opened it to private investors. That is exactly where investors and advisers should now be looking - and where a specialist manager, close enough to the technology to read it, earns its place.

→ Explore EverQuest’s investment approach